Oxitec and the Gorgas Institute in Panama today announce the result of the outdoor pilot of Oxitec OX513A, an engineered strain of the Aedes aegypti mosquito. The outcome was a reduction of over 90% in the local population of the Aedes aegypti mosquito, which transmits the dengue and chikungunya viruses.
29 January, 2015
In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's disease.
28 January, 2015
A research article published Science presents the first major analysis based on the Human Protein Atlas, including a detailed picture of the proteins that are linked to cancer, the number of proteins present in the bloodstream, and the targets for all approved drugs on the market.
27 January, 2015
Scripps Florida Scientists Develop Novel Platform for Treatment of Breast, Pancreatic Cancer
16 January, 2015
A team led by scientists at The Scripps Research Institute (TSRI) has identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited neurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that inhibit this enzyme.
15 January, 2015
CANCER RESEARCH UK scientists have taken steps to overcome drug resistance in glioblastoma, the most common type of brain tumour in adults, according to research published in Molecular Cancer Therapeutics today (Wednesday).
14 January, 2015
MedCity Executive Chair Dr Eliot Forster has been announced as the new chief executive officer of Immunocore, a leading Oxford-based biotech company focused on the discovery and development of novel cancer therapies.
13 January, 2015